Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Cuevas

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nature|October 30, 2024
Pharmacological restoration of GTP hydrolysis by mutant RASAntonio Cuevas-Navarro, Yasin Pourfarjam, Feng Hu, et al.
Science (New York, N.Y.)|March 16, 2019
RIT1 oncoproteins escape LZTR1-mediated proteolysisPau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
The Journal of Nutritional Biochemistry|December 5, 2016
High-fat diet induces metabolic changes and reduces oxidative stress in female mouse heartsIgnasi Barba, Elisabet Miró-Casas, José L Torrecilla, et al.
The Science of the Total Environment|September 6, 2020
Environmental refuges increase performance of juvenile mussels Mytilus chilensis: Implications for mussel seedling and farming strategiesN Jahnsen-Guzmán, N A Lagos, M A Lardies, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2021
RAS interaction with Sin1 is dispensable for mTORC2 assembly and activityPau Castel, Srisathiyanarayanan Dharmaiah, Matthew J Sale, et al.
Science Advances|July 14, 2023
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophyAntonio Cuevas-Navarro, Morgan Wagner, Richard Van, et al.
Cancer Research|July 11, 2025
RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung AdenocarcinomaAlessandro M Mozzarelli, Antonio Cuevas-Navarro, Emily G Shuldiner, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Cell|May 7, 2026
Disrupted molecular glue complex drives RAS inhibitor resistanceBen Sang, Ling Feng Ye, Zheng Fu, et al.
Cancer Discovery|July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nature|October 30, 2024
Pharmacological restoration of GTP hydrolysis by mutant RASAntonio Cuevas-Navarro, Yasin Pourfarjam, Feng Hu, et al.
Science (New York, N.Y.)|March 16, 2019
RIT1 oncoproteins escape LZTR1-mediated proteolysisPau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
The Journal of Nutritional Biochemistry|December 5, 2016
High-fat diet induces metabolic changes and reduces oxidative stress in female mouse heartsIgnasi Barba, Elisabet Miró-Casas, José L Torrecilla, et al.
The Science of the Total Environment|September 6, 2020
Environmental refuges increase performance of juvenile mussels Mytilus chilensis: Implications for mussel seedling and farming strategiesN Jahnsen-Guzmán, N A Lagos, M A Lardies, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2021
RAS interaction with Sin1 is dispensable for mTORC2 assembly and activityPau Castel, Srisathiyanarayanan Dharmaiah, Matthew J Sale, et al.
Science Advances|July 14, 2023
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophyAntonio Cuevas-Navarro, Morgan Wagner, Richard Van, et al.
Cancer Research|July 11, 2025
RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung AdenocarcinomaAlessandro M Mozzarelli, Antonio Cuevas-Navarro, Emily G Shuldiner, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Cell|May 7, 2026
Disrupted molecular glue complex drives RAS inhibitor resistanceBen Sang, Ling Feng Ye, Zheng Fu, et al.
Cancer Discovery|July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Pageof 3